US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 13.960
  • -0.210-1.48%
Trading Nov 19 13:51 ET
1.42BMarket Cap-2561P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept ARK Portfolio
ARK Portfolio
Intraday+1.45%
Gene Editing
Gene Editing
Intraday-1.65%